Browsing by Subject "immune checkpoint inhibitors"
Now showing items 1-4 of 4
|Molecular profiling of the metaplastic spindle cell carcinoma of the breast reveals potentially targetable biomarkers ||2020||Elsevier||Article|
|Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors. ||2017||AME Publishing Company||Article|
|PD-L1 status in breast cancer: Current view and perspectives. ||2019||Elsevier||Article|
|Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer. ||2019||Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina||Article Review|